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Abstract
This Application Note describes the benefits of the Agilent 2100 bioana-
lyzer in real-time quantitative PCR (QPCR) experiments. The results
show that the Agilent 2100 bioanalyzer is an indispensable tool to:
• ensure experimental success by verifying RNA template quality prior to
QPCR experiments
￿ improve the assay design and validation process by monitoring size and
purity of the QPCR amplicons. 
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Real-time quantitative PCR (QPCR)
is a highly sensitive method to
assess gene expression changes in
biological systems. As for all experi-
mental designs, high quality starting
material is essential for the success
of the experiment. In microarray
applications, validation of RNA tem-
plate quality using the Agilent 2100
bioanalyzer with its associated RNA
integrity number (RIN) algorithm is
a widely accepted and commonly
used technique to ensure best possi-
ble results.1,2 Especially RIN has
been established as the standard
tool for assessing RNA integrity. 3,4
There are various mechanisms by
which RNA can be degraded either
at the 5’ or 3’ end. Not knowing the
extent of possible degradation can
lead to false negative results or mis-
interpretation of data if the ampli-
con falls into a degraded region.
Therefore, the degradation level of
RNA samples is an important para-
meter to monitor when designing
primers and probes for QPCR. An
amplicon biased towards the mRNA
ends or a longer amplicon (>100 bp)
might fail to amplify if the RNA is
highly degraded as in archival sam-
ples of FFPE tissue. Knowing of the
template quality allows to accomo-
date the amplicon design and
reverse transcription (RT) priming
strategy, ensuring experimental suc-
cess. 
In addition to RNA quality control,
an important part of the assay
design process in QPCR is the vali-
dation of the newly designed set of
primers and probes. This is usually
done by checking primer binding
specificity using a SYBR Green
chemistry analyzing melt curve data.
The sensitivity of the assay is vali-
dated by assessing the linear dynam-
ic range using a standard curve over
a wide range of concentrations of a
positive control. However, due to
the properties of SYBR Green, the
resolution of a melt curve is limited.
This can make it challenging to iden-
tify specificity if the product melts at
similar temperatures as primer
dimers. In addition, the melt curve
analysis can not show the size of the
amplicon generated. 
Here we show how the Agilent 2100
bioanalyzer can be used to assess
the level of degradation of the RNA
starting material. In addition, to
overcome the limitations of a SYBR
Green based melt curve analysis,
sizes and purity of all amplicons
were assessed with the DNA 1000
assay on the Agilent 2100 bioanalyzer.
Materials and methods
RNA purification
Total RNA was purified from
5x106 HEK cells using Stratagene's
Absolutely RNA Miniprep Kit . 
All experimental steps were con-
ducted according to the manufac-
turer’s description including an
on-column DNase digest. The RNA
was eluted in 30 µL pre-warmed
elution buffer.
RNA quantification 
1 µL of the RNA was measured
using the Agilent 2100 bioanalyzer
and a NanoDrop spectrophotome-
ter. The RNA was diluted 1:5 for
quality control.
RNA quality control
1 µL of the total RNA and of the
RNA degradation reactions were
analyzed with the RNA 6000 Nano
assay on the Agilent 2100 bioana-
lyzer to assess the level of degra-
dation as indicated by the RIN
number. 
RNA degradation
4 µg of RNA in a total volume of
12 µL were used for each time-
point of the degradation. The RNA
was thermally degraded using dif-
ferent incubation periods at 70 °C.
3 µL of the degradation reaction
were immediately used in a subse-
quent RT reaction. 
Reverse transcription
1 µg of total RNA from HEK cells
was reverse transcribed using
Stratagene’s AffinityScript QPCR
cDNA Synthesis Kit at 55 °C for 
30 minutes in a 20 µL reaction.
The cDNA was diluted to 100 µl
before use in real-time quantita-
tive PCR.
Real-time quantitative PCR 
All QPCR experiments were per-
formed on Stratagene’s Mx3005P
QPCR system.
Primers:
GAPDH (Ensembl gene ID
ENSG00000111640):
GAPDH 5’ forward 5’-TCGGAGT-
CAACGGATTTGGTCG-3’
GAPDH 5’ reverse 5’-TAAACCAT-
GTAGTTGAGGTCAATGAAGG-3’
Amplicon size 118 bp
GAPDH 3’ forward 5’-AAGCT-
CATTTCCTGGTATGACAACG-3’
GAPDH 3’ reverse 5’-TCTTC-
CTCTTGTGCTCTTGCTGG-3’
Amplicon size 126 bp
HPRT1 (Ensembl gene ID
ENSG00000165704):
HPRT1 5’ forward 5’-CGTCGT-
GATTAGTGATGATGAACCAG-3’
2HPRT1 5’ reverse 5’-AGCAA-
GACGTTCAGTCCTGTCC-3’
Amplicon size 130 bp
HPRT1 3’ forward 5’-
TTCAGGGATTTGAATCAT-
GTTTGTGTC-3’
HPRT1 3’ reverse 5’-GCGATGT-
CAATAGGACTCCAGATG-3’
Amplicon size 114 bp
YWHAZ (Ensembl gene ID
ENSG00000164924):
YWHAZ 5’ forward 5’-TTGAGACG-
GAGCTAAGAGATATCTGC-3’
YWHAZ 5’ reverse 5’-GCAAC-
CTCAGCCAAGTAACGG-3’
Amplicon size 142 bp
YWHAZ 3’ forward 5’-CTTC-
CTTTGCTTGCATCCCACAG-3’
YWHAZ 3’ reverse 5’-GACAAT-
GACAGACCATTCAGGATAGG-3’
Amplicon size 128 bp
Primers were designed to span
exon junctions where possible
with the exception of YWHAZ
where the 5’ assay has the primers
in exon 2 and 3 with a 23.6 kb
intron in between and the 3’ assay
is located in exon 6. 
Primers were used at 100 nM final
concentration in the PCR.
Thermoprofile:
Taq activation: 95 °C 10 minutes
Cycling:  95 °C 20 s, 60 °C 
20 s, 72 °C 20 s for 
40 cycles with 
measurement on 
60 °C
Melt curve 
analysis:   95 °C 30 s, 60 °C 30 s,
95 °C 30 s with con-
tinuous measurement
along the ramp from
60 °C to 95 °C.
Reactions were carried out in 
20 µL using Stratagene's Brilliant
II SYBR Green QPCR mastermix.
DNA amplicon analysis:
To assess size and purity of QPCR
amplicons, 1 µl of the QPCR reac-
tions was analyzed with the DNA
1000 assay on the Agilent 2100
bioanalyzer according to manufac-
turer’s instructions.  
Results and discussion
QPCR assay validation
To validate the specificity of the
primer design and to determine the
best possible RT priming strategy,
QPCR and bioanalyzer tests were
conducted for 3 genes (GAPDH,
HPRT1 and YWHAZ) by using high
quality RNA (RIN = 10) as template. 
The purified intact RNA (figure 1)
was reverse transcribed with either
oligo-dT or random priming. As the
results for all three genes were high-
ly similar, QPCR and bioanalyzer
validation results for GAPDH are
exemplarily shown in figure 2. Oligo-
dT primed cDNA gave earlier Ct 
values compared to random prim-
ing. In addition, all No Reverse
Transcriptase (NoRT) controls were
negative indicating no amplification
from potential genomic DNA conta-
mination. Analyses of the QPCR
amplicons on the Agilent 2100 bio-
analyzer showed a slight deviation
of amplicon sizes from the expected
size (sizing results for GAPDH
amplicons are exemplarily shown in
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Figure 1
Quality control of purified total RNA. Total RNA was purified from 5x106 HEK cells and analyzed
on the 2100 bioanalyzer. The value of 10 obtained for the RIN shows the very high integrity of the
purified sample. figure 2). Reasons could be that 1 µL
of the amplification reaction was
used directly for the analysis includ-
ing SYBR Green and salts, which
could introduce a skew.
Usually, no-template-controls (NTC)
assess contamination and potential
primer dimer formation. This is
always recommended to perform
since a small amount of contaminat-
ing template can lead to amplifica-
tion. For the HPRT1 5’ assay one of
the NTC was positive, showing a
peak in the melt curve at a similar
melting temperature compared to
the positive control (figure 3A). To
verify that no contamination of the
well has occurred, the NTC was ana-
lyzed using the DNA 1000 assay on the
Agilent 2100 bioanalyzer (figure 3B).
The run showed that two minor
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Figure 2
Assay Validation: Amplification plots, melt curve and bioanalyzer analysis of amplicons for GAPDH. A) 5’-assay, B) 3’-assay.
Figure 3
Validation of positive NTC results. Melt curve and bioanalyzer analysis of HPRT1 5’-amplicons. Enlargement of melt curve clearly shows a product
in the NTC control with similar Tm to the positive control. Bioanalyzer analysis shows two minor peaks of 21 and 51 bp pointing to primer dimer 
formation. 
A
B
oligo-dT Size: 110 bp
Size: 121 bp
random
oligo-dT
random
AB
NTC Size: 21 + 51 bppeaks could be detected at 21 and
51 bp which are most probably relat-
ed to primer and primer dimers.
This highlights the high information
content obtained by the Agilent 2100
bioanalyzer and the poor discrimina-
tion capabilities of a SYBR Green
based melt curve.
Monitoring the impact of RNA degra-
dation on QPCR experiments
To evaluate the effect of RNA
degradation in a QPCR experi-
ment, we used a set of thermally
degraded RNA and monitored the
level of degradation on the Agilent
2100 bioanalyzer. The degraded
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Figure 4
Analysis of thermally degraded RNA samples. Total RNA was degraded at 70 °C for varying time and analyzed on the Agilent 2100 bionalyzer. The
resulting electropherograms and RIN numbers after 0, 30, 45, 75 minutes of incubation are shown respectively in A, B, C, and D.
RNA samples were used to detect
the amount of 3 different mRNA
targets (GAPDH, HPRT1 and
YWHAZ). To further investigate
the degradation effect on QPCR
results, amplicons were designed
targeting both the 5’ as well as 3’
end of the respective mRNAs.
The untreated high quality total
RNA was subjected to thermal
degradation at 70 °C for various
times between 0 and 75 minutes.
The equivalent volume to 1 µg of
RNA was immediately used in a
RT reaction. The degradation state
of each sample was analyzed with
the RNA Nano assay on the
A
C
B
D
RIN 8.9
0 min
RIN 6.5
30 min
RIN 4.6
45 min
RIN 2.3
75 min
Agilent 2100 bioanalyzer. The
samples used in this experiment
ranged from intact RNA (RIN 8.9) to
highly degraded (RIN 2.3) (figure 4).
For each of the above samples
QPCR was carried out to quantify
the amount of 5’ and 3’ ends of the
messengers for GAPDH, HPRT1
and YWHAZ. Relative quantities of
the respective cDNA copies
towards intact RNA (RIN 8.9)
were calculated. A significant dif-
ference in the relative quantities is
observed for all samples with RIN
4.6 and below. The most dramatic
changes occur below a RIN of 4.6. In addition, for highly degraded
RNA (RIN 2.3) the extent of
degradation differs for 5’ and 3’
end and seems to be gene specific
(figure 5). The data shows clearly
that under the conditions used
there is a differential degradation
of 5’ and 3’ end of mRNA result-
ing in a faster loss of 5’ vs 3’ end
both for GAPDH and HPRT1.
YWHAZ showed a slightly differ-
ent behavior in having a preferen-
tial loss of the 3’ end at highly
degraded stages.
The presented data indicates that
the integrity of RNA templates
can influence the outcome of a
QPCR experiment. Furthermore,
depending on the position of the
amplicon major differences of the
calculated fold-change in a com-
parative quantification can occur. 
Conclusion
In QPCR assay validation it is
essential to have a more accurate
validation of specificity than pro-
vided by a simple melt curve
analysis. This is especially impor-
tant if negative controls show
amplification products with high-
ly similar melting temperatures.
Analyses of the QPCR validation
amplicons on the Agilent 2100
bioanalyzer allowed discrimina-
tion of primer dimers from target
amplicons which could not be
achieved by standard melt point
analysis
Due to the differential degrada-
tion of the 5’ and 3’ end of mRNA,
the position of the amplicon can
have a strong influence on the
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Figure 5
Relative quantities of amplicons positioned at the 5' or 3' end of three target genes. QPCR results
derived from differentially degraded RNA templates compared with highly intact RNA (RIN 8.9).
The Y-axis scale is logarithmic to base 2.
A) GAPDH, B) HPRT1, C) YWHAZ. Blue: 5’-assay; violet: 3’-assayresults. The results of our experi-
ments indicate that the amount
and directionality of degradation
are highly gene-dependent and
that the most pronounced effects
appears below a RIN of 4.6. These
data highlights the importance of
a highly reproducible RNA integri-
ty assessment for QPCR assay
design and subsequent routine
measurement. 
The data presented show how the
Agilent 2100 bioanalyzer was suc-
cessfully implemented in a QPCR
workflow to monitor essential
experimental parameters as tem-
plate quality and assay specificity.
References
1.
Virginie Copois, Frédéric Bibeau,
Caroline Bascoul-Mollevi, Nicolas
Salvetat, Patrick Chalbos, Corinne
Bareil, Laurent Candeil, Caroline
Fraslon, Emmanuel Conseiller,
Virginie Granci, Pierre Mazière,
Andrew Kramar, Marc Ychou,
Bernard Pau, Pierre Martineau,
Franck Molina, Maguy Del Rio
“Impact of RNA degradation on
gene expression profiles:
Assessment of different methods
to reliably determine RNA quality.”
J Biotechnol., Jan 20;127(4):549-
59, 2006.
2.
Strand C, Enell J, Hedenfalk I,
Fernö M. “RNA quality in frozen
breast cancer samples and the
influence on gene expression
analysis--a comparison of three
evaluation methods using micro-
capillary electrophoresis traces.”
BMC Mol Biol., May 22;8:38,
2007.
7
3.
Schroeder A, Mueller O, Stocker S,
Salowsky R, Leiber M, Gassmann
M, Lightfoot S, Menzel W,
Granzow M, Ragg T., “The RIN: an
RNA integrity number for assign-
ing integrity values to RNA mea-
surements.” BMC Mol Biol., Jan
31;7:3, 2006.
4.
Imbeaud S, Graudens E,
Boulanger V, Barlet X, Zaborski P,
Eveno E, Mueller O, Schroeder A,
Auffray C. “Towards standardiza-
tion of RNA quality assessment
using user-independent classifiers
of microcapillary electrophoresis
traces.” Nucleic Acids Res., Mar
30;33(6):e56, 2005.© 2008 Agilent Technologies, Inc.
Published January 1, 2008
Publication Number 5989-7730EN 
www.agilent.com/chem/2100 
Steffen Mueller is an Application
Specialist at Stratagene, an
Agilent Technologies company.